NO20050132L - Vaksinesammensetning som omfatter blanding av multivalente meningokokk yttermembran vesikler - Google Patents
Vaksinesammensetning som omfatter blanding av multivalente meningokokk yttermembran vesiklerInfo
- Publication number
- NO20050132L NO20050132L NO20050132A NO20050132A NO20050132L NO 20050132 L NO20050132 L NO 20050132L NO 20050132 A NO20050132 A NO 20050132A NO 20050132 A NO20050132 A NO 20050132A NO 20050132 L NO20050132 L NO 20050132L
- Authority
- NO
- Norway
- Prior art keywords
- blend
- outer membrane
- vaccine composition
- membrane vesicles
- meningococcal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
Abstract
Den foreliggende oppfinnelsen vedrører vaksinesammensetninger for den effektive forebyggingen eller behandlingen av neisserial, helst meningokokk sykdom. Vaksinene i oppfinnelsen omfatter en flerverdig meningokokkvesikkelsammensetning som omfatter minst en vesikkel med homolog bakteriedrepende aktivitet som er utledet fra en meningokokkstamme med en serosubtype som er alminnelig i det land hvor den skal anvendes, og minst en vesikkel med heterolog bakteriedrepende aktivitet som er utledet fra en meningokokkstamme som ikke trenger å ha en serosubtype som er alminnelig i landet der den skal anvendes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0213622.4A GB0213622D0 (en) | 2002-06-13 | 2002-06-13 | Vaccine Corporation |
PCT/EP2003/006094 WO2003105890A2 (en) | 2002-06-13 | 2003-06-10 | Vaccine composition |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20050132D0 NO20050132D0 (no) | 2005-01-11 |
NO20050132L true NO20050132L (no) | 2005-02-11 |
Family
ID=9938532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050132A NO20050132L (no) | 2002-06-13 | 2005-01-11 | Vaksinesammensetning som omfatter blanding av multivalente meningokokk yttermembran vesikler |
Country Status (20)
Country | Link |
---|---|
US (1) | US20060110412A1 (no) |
EP (1) | EP1565211A2 (no) |
JP (1) | JP2005531614A (no) |
KR (1) | KR20050049431A (no) |
CN (1) | CN100387298C (no) |
AR (1) | AR040204A1 (no) |
AU (1) | AU2003236734A1 (no) |
BR (1) | BR0311777A (no) |
CA (1) | CA2488782A1 (no) |
CL (1) | CL2003001192A1 (no) |
CU (1) | CU23552A1 (no) |
GB (1) | GB0213622D0 (no) |
MX (1) | MXPA04012568A (no) |
NO (1) | NO20050132L (no) |
NZ (1) | NZ560766A (no) |
PE (1) | PE20040562A1 (no) |
RU (1) | RU2005100509A (no) |
UY (1) | UY27843A1 (no) |
WO (1) | WO2003105890A2 (no) |
ZA (1) | ZA200409547B (no) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA03000822A (es) | 2000-07-27 | 2004-11-01 | Childrens Hosp & Res Ct Oak | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis. |
GB2414667A (en) * | 2004-06-03 | 2005-12-07 | Isis Innovation | Vaccine compositions of N. meningitidis PorA and FetA antigens |
GB0419627D0 (en) * | 2004-09-03 | 2004-10-06 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
CN101107007B (zh) | 2005-01-27 | 2011-08-17 | 奥克兰儿童医院及研究中心 | 对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗 |
AR058707A1 (es) * | 2005-12-22 | 2008-02-20 | Glaxosmithkline Biolog Sa | Vacuna, procedimiento para fabricarla y su uso |
ES2387582T3 (es) | 2006-09-07 | 2012-09-26 | Glaxosmithkline Biologicals S.A. | Vacuna de combinación con cantidades reducidas del antígeno del virus de la polio |
DK2200642T3 (da) | 2007-10-19 | 2012-07-16 | Novartis Ag | Meningococvaccinepræparater |
EP2217250A4 (en) | 2007-11-09 | 2011-01-05 | California Inst Of Techn | IMMUNOREGULATORY COMPOUNDS AND RELATED COMPOSITIONS AND METHODS |
US8404457B2 (en) * | 2008-02-01 | 2013-03-26 | Sanofi Pasteur Limited | Assay for diagnosing Streptococcus pneumoniae |
US8466167B2 (en) | 2008-03-03 | 2013-06-18 | Irm Llc | Compounds and compositions as TLR activity modulators |
CA2747340A1 (en) | 2008-12-17 | 2010-06-24 | Novartis Ag | Meningococcal vaccines including hemoglobin receptor |
CA2765112A1 (en) | 2009-06-10 | 2010-12-16 | Novartis Ag | Benzonaphthyridine-containing vaccines |
CN102740882A (zh) | 2009-08-27 | 2012-10-17 | 诺华有限公司 | 含有铝、寡核苷酸和聚阳离子的佐剂 |
ES2443952T3 (es) | 2009-09-02 | 2014-02-21 | Novartis Ag | Composiciones inmunógenas que incluyen moduladores de la actividad de TLR |
JO3257B1 (ar) | 2009-09-02 | 2018-09-16 | Novartis Ag | مركبات وتركيبات كمعدلات لفاعلية tlr |
EP2486940B1 (en) * | 2009-10-08 | 2017-10-04 | Aeon Medix Inc. | Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof |
WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
US9408907B2 (en) | 2009-12-15 | 2016-08-09 | Glaxosmithkline Biologicals Sa | Homogenous suspension of immunopotentiating compounds and uses thereof |
CA2783955A1 (en) * | 2009-12-22 | 2011-06-30 | Sanofi Pasteur Limited | Immunogenic compositions |
CA2793510A1 (en) | 2010-03-18 | 2012-02-16 | Novartis Ag | Adjuvanted vaccines for serogroup b meningococcus |
EP2549990A1 (en) | 2010-03-23 | 2013-01-30 | Irm Llc | Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
JP6027961B2 (ja) * | 2010-04-07 | 2016-11-16 | シェン, ユエSHEN, Yue | 粘膜へ化合物を送るための媒体、それに関連する組成物、方法、及びシステム |
AU2011300418B2 (en) * | 2010-09-10 | 2016-05-12 | Glaxosmithkline Biologicals Sa | Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom |
WO2012153302A1 (en) | 2011-05-12 | 2012-11-15 | Novartis Ag | Antipyretics to enhance tolerability of vesicle-based vaccines |
WO2013009945A1 (en) | 2011-07-12 | 2013-01-17 | The Brigham And Women's Hospital, Inc. | Lipid-containing psa compositions, methods of isolation and methods of use thereof |
RU2014135522A (ru) | 2012-02-02 | 2016-03-27 | Новартис Аг | Промоторы для увеличенной экспрессии белка у менингококка |
US10598666B2 (en) | 2012-03-08 | 2020-03-24 | Glaxosmithkline Biologicals Sa | In vitro potency assay for protein-based meningococcal vaccines |
NZ630133A (en) | 2012-06-14 | 2016-10-28 | Novartis Ag | Vaccines for serogroup x meningococcus |
US9526776B2 (en) | 2012-09-06 | 2016-12-27 | Glaxosmithkline Biologicals Sa | Combination vaccines with serogroup B meningococcus and D/T/P |
WO2016201342A1 (en) | 2015-06-10 | 2016-12-15 | California Institute Of Technology | Sepsis treatment and related compositions methods and systems |
EP3337321A4 (en) | 2015-08-19 | 2019-07-17 | President and Fellows of Harvard College | LIPIDED PSA COMPOSITIONS AND METHOD |
US11491181B2 (en) | 2016-07-15 | 2022-11-08 | President And Fellows Of Harvard College | Glycolipid compositions and methods of use |
CA3035320A1 (en) | 2016-09-02 | 2018-03-08 | Glaxosmithkline Biologicals Sa | Vaccines for neisseria gonorrhoeae |
CA3166272A1 (en) * | 2020-10-23 | 2022-04-28 | Omvax, Inc. | Compositions and methods for vaccination against neisseria gonorrhoeae |
GB202115077D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Assay |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU748973B2 (en) * | 1997-07-17 | 2002-06-13 | Baxter Healthcare Sa | Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide |
GB9918319D0 (en) * | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
MXPA03000822A (es) * | 2000-07-27 | 2004-11-01 | Childrens Hosp & Res Ct Oak | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis. |
-
2002
- 2002-06-13 GB GBGB0213622.4A patent/GB0213622D0/en not_active Ceased
-
2003
- 2003-06-10 CA CA002488782A patent/CA2488782A1/en not_active Abandoned
- 2003-06-10 WO PCT/EP2003/006094 patent/WO2003105890A2/en active Application Filing
- 2003-06-10 NZ NZ560766A patent/NZ560766A/en not_active IP Right Cessation
- 2003-06-10 BR BR0311777-4A patent/BR0311777A/pt not_active IP Right Cessation
- 2003-06-10 EP EP03735599A patent/EP1565211A2/en not_active Ceased
- 2003-06-10 RU RU2005100509/13A patent/RU2005100509A/ru not_active Application Discontinuation
- 2003-06-10 CL CL200301192A patent/CL2003001192A1/es unknown
- 2003-06-10 US US10/529,064 patent/US20060110412A1/en not_active Abandoned
- 2003-06-10 JP JP2004512791A patent/JP2005531614A/ja active Pending
- 2003-06-10 AU AU2003236734A patent/AU2003236734A1/en not_active Abandoned
- 2003-06-10 KR KR1020047019991A patent/KR20050049431A/ko not_active Application Discontinuation
- 2003-06-10 CN CNB038162822A patent/CN100387298C/zh not_active Expired - Fee Related
- 2003-06-10 MX MXPA04012568A patent/MXPA04012568A/es not_active Application Discontinuation
- 2003-06-11 AR ARP030102096A patent/AR040204A1/es not_active Application Discontinuation
- 2003-06-11 UY UY27843A patent/UY27843A1/es unknown
- 2003-06-11 PE PE2003000583A patent/PE20040562A1/es not_active Application Discontinuation
-
2004
- 2004-11-25 ZA ZA200409547A patent/ZA200409547B/en unknown
- 2004-12-10 CU CU20040285A patent/CU23552A1/es active IP Right Grant
-
2005
- 2005-01-11 NO NO20050132A patent/NO20050132L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1565211A2 (en) | 2005-08-24 |
CU23552A1 (es) | 2010-07-20 |
CA2488782A1 (en) | 2003-12-24 |
WO2003105890A2 (en) | 2003-12-24 |
MXPA04012568A (es) | 2005-09-21 |
CL2003001192A1 (es) | 2005-01-07 |
UY27843A1 (es) | 2003-12-31 |
AR040204A1 (es) | 2005-03-16 |
BR0311777A (pt) | 2005-03-29 |
WO2003105890A3 (en) | 2004-03-25 |
JP2005531614A (ja) | 2005-10-20 |
KR20050049431A (ko) | 2005-05-25 |
CN1668329A (zh) | 2005-09-14 |
NO20050132D0 (no) | 2005-01-11 |
AU2003236734A1 (en) | 2003-12-31 |
NZ560766A (en) | 2009-09-25 |
PE20040562A1 (es) | 2004-10-19 |
CN100387298C (zh) | 2008-05-14 |
GB0213622D0 (en) | 2002-07-24 |
ZA200409547B (en) | 2006-07-26 |
US20060110412A1 (en) | 2006-05-25 |
RU2005100509A (ru) | 2006-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050132L (no) | Vaksinesammensetning som omfatter blanding av multivalente meningokokk yttermembran vesikler | |
MX2010012999A (es) | Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso. | |
NL300897I2 (nl) | Neisseira meningitidis serogroep B recombinant gelipideerd fHbp subfamilie A05 eiwit | |
MY149591A (en) | Vaccines comprising l2 and/or l3 los from neisseria | |
MX2010004549A (es) | Composiciones y métodos bacteriostáticos o bactericidas. | |
NO20080284L (no) | Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer | |
NO20073868L (no) | Levende attenuert rotavirus vaksine for oral administrering | |
NZ593674A (en) | Meningococcal vaccines including hemoglobin receptor | |
MX2009006760A (es) | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedades meningococicas. | |
NO20050664L (no) | 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer | |
EA200870393A1 (ru) | Новые композиции для нарушений волос и способ получения композиций | |
BR0015961A (pt) | Antìgeno de neisseria de 85kda | |
NO20070746L (no) | Anvendelse av fosfaterte alkanoler som dispergente , emulgatorer, hydrotroper, fuktmidler og kompatabilitetsstoffer i blandinger for jordbruket. | |
NO20065835L (no) | Medikamenter som inneholder N-sulfamoyl-N'-arylpiperaziner for profylakse eller behandling av overvekt og beslektede tilstander | |
NO20090290L (no) | Polyvalent vaksine mot salmonid alfavirusinfeksjoner | |
DE60142786D1 (de) | Zusammensetzungen und methoden zur behandlung von candidosen | |
NO20063017L (no) | Protein NMB0928 og anvendelse derav i farmasoytiske formuleringer | |
JP2024050169A (ja) | ジンジパインのプロテアーゼ活性阻害剤、及び口腔用組成物 | |
ATE424844T1 (de) | Kombinationsvakzine für geflügel | |
Norheim et al. | Prevention of serogroup A, C and W135 meningococcal disease in Africa with outer membrane vesicle vaccines | |
IS5075A (is) | 1-fenýlalkýl-1,2,3,6-tetrahýdrópýrídín til meðhöndlunar Alzheimer-sjúkdómsins | |
DK1660121T3 (da) | Levende svækket bakteriel vaccine | |
NO20072090L (no) | Forbindelser, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav II | |
NO20072091L (no) | Forbindelser, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav III | |
AR047263A1 (es) | Proteina nmb1125 y su uso en formulaciones farmaceuticas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |